Biden administration lists 10 drugs for Medicare price negotiation

The Biden administration announced the first 10 prescription drugs that have been selected for Medicare price negotiations Monday morning.

The list released by the Department of Health and Human Services (HHS) includes several well-known drugs like Pfizer and Bristol Myers Squibb’s Eliquis, Eli Lilly and Boehringer Ingelheim’s Jardiance as well as AstraZeneca’s Farxiga.